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Abstract
Background: The preimplantation embryo is sensitive to culture conditions in vitro and poor maternal diet in vivo.
Such environmental perturbations can have long-lasting detrimental consequences for offspring health and
physiology. However, early embryo susceptibility to other aspects of maternal health and their potential long-term
influence into adulthood is relatively unexplored. In this study, we established an in vivo mouse model of maternal
periconceptional systemic inflammation by intraperitoneal lipopolysaccharide (LPS) administration on the day of
zygote formation and investigated the consequences into adulthood.
Results: In the short term, maternal LPS challenge induced a transient and typical maternal sickness response
(elevated serum proinflammatory cytokines and hypoactive behaviour). Maternal LPS challenge altered
preimplantation embryo morphogenesis and cell lineage allocation, resulting in reduced blastocyst inner cell mass
(ICM) cell number and a reduced ICM:trophectoderm cell ratio. In the long term, diverse aspects of offspring
physiology were affected by maternal LPS treatment. Whilst birthweight, growth and adult blood pressure were
unaltered, reduced activity in an open-field behaviour test, increased fat pad:body weight ratio and increased body
mass index were observed in male, but not female, offspring. Most importantly, the maternal LPS challenge caused
corticosterone-independent blunting of the serum proinflammatory cytokine response to innate immune challenge
in both male and female offspring. The suppressed state of innate immunity in challenged offspring was dose-
dependent with respect to the maternal LPS concentration administered.
Conclusions: These results demonstrate for the first time that the preimplantation embryo in vivo is sensitive to
maternal systemic inflammation, with effects on blastocyst cell lineage allocation and consequences for behaviour,
adiposity and innate immune response in adult offspring. Critically, we identify a novel mechanism mediated
through maternal-embryonic interactions that confers plasticity in the development of the innate immune system,
which is potentially important in setting postnatal tolerance to environmental pathogens. Our study extends the
concept of developmental programming of health and disease to include maternal health at the time of conception.
Background
Substantial evidence supports the concept that adult
health and physiology are influenced by environmental
factors during the gestational and infant stages of devel-
opment [1-3]. The developmental origins of health and
disease (DOHaD) hypothesis proposes that such
programming may be contributing to the increasing pre-
valence of hypertension, diabetes and other noncommu-
nicable diseases in recent decades [1]. Programming can
be initiated even during the periconceptional period: the
preimplantation embryo has proven sensitive to environ-
mental perturbation mediated through maternal diet or
in vitro culture, with concomitant postnatal dysfunction
of cardiovascular, metabolic and behavioural systems
[2-6]. Whether other aspects of periconceptional mater-
nal health (for example, infection, inflammation) can
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explored in detail.
Inflammation is associated with the release of potent
cellular mediators (for example, cytokines, glucocorti-
coids (GCs)) which communicate at autocrine and para-
crine levels. Such mediators alter and regulate
homeostasis and may modify the developmental envir-
onment. Maternal infection and inflammation during
mid- to late gestation affects offspring behaviour [7,8],
immunity [9-11], metabolic status [12] and hypothala-
mic-pituitary-adrenal (HPA) axis functioning [13]. Little
is known about the postnatal sequelae of maternal
inflammation during the periconceptional period,
although an association with an increased risk of schizo-
phrenia has been reported [14,15]. In this study, we
established an in vivo mouse model of maternal pericon-
ceptional systemic inflammation (MPSI) by lipopolysac-
charide (LPS) administration on the day of zygote
formation.
We found that the maternal LPS challenge induces a
typical and transient sickness response and, critically,
altered developmental programming with abnormal
blastocyst cell lineage allocation and led to postnatal
changes in behaviour, adiposity and, following innate
immune challenge, in cytokine release. Our study there-
fore establishes that maternal sickness at the time of
conception, or immune response conditions associated
with it, can have lifelong consequences on offspring
health, thereby extending the concept of DOHaD. More-
over, our data show for the first time that the respon-
siveness of the innate immune system in an adult
mammal is subject to environmental conditions origi-
nating at the time of conception.
Results
Maternal inflammatory response
Intraperitoneal administration of LPS (10, 50 or 150 μg/
kg dose vs. control) into dams at gestational day (GD)
0.5 (zygote stage) induced a typical sickness response,
including associated metabolic and behavioural changes
(Figure 1). One hour after treatment LPS-injected mice
displayed reduced open-field activity, including a 90% to
95% reduction in jumping activity (P <0 . 0 0 1f o ra l l
doses) and increased time spent resting (P <0 . 0 5a t5 0
and 150 μg/kg LPS doses) (Figure 1A). At 24 hours
post-LPS injection, food consumption was reduced at all
doses (10% to 12% reduction; P < 0.001) (Figure 1B), as
was water consumption at the 50 and 150 μg/kg LPS
doses.
(P ≤ 0.006) (Figure 1B). Thereafter food and water
consumption were unchanged between treatment groups
(Figure 1B). Body weight at 24 hours was reduced by
3.8% to 5.7% in an LPS dose-dependent manner (P <
0.001 at 50 and 150 μg/kg and P < 0.01 at 10 μg/kg LPS
doses) (Figure 1C). Body weight was similarly reduced at
48 hours (4.2% to 4.5% reduction; P ≤ 0.003) (Figure
1C) but returned to control levels by 72 hours (Figure
1C). A selection of the 23 cytokines detected by multi-
plex assay in maternal serum at 3 to 72 hours posttreat-
ment is shown in Figure 1D, and the remaining
cytokines are shown in Figure S1 in Additional file 1.
Serum concentrations of most cytokines peaked at three
hours post-LPS treatment, with the 150 μg/kg LPS dose
resulting in a three- to fivefold increase in IL-1b,I L - 3 ,
IL-10, eotaxin, granulocyte-macrophage colony-stimulat-
ing factor (GM-CSF) and macrophage inflammatory
protein 1a (MIP-1a; CCL3) (P < 0.05). Greater increases
were seen at three hours in IL-12 p40 (48-fold; P =
0.001), monocyte chemoattractant protein 1 (MCP-1;
CCL2) (58-fold; P =0 . 0 0 4 )a n dr e g u l a t e du p o na c t i v a -
tion, normal T-cell expressed and secreted (RANTES;
CCL5) (52-fold; P = 0.044). At 48 hours, most cytokine
levels from LPS-treated groups were similar to those of
controls; however, some levels remained elevated (IL-6,
IL-12 p70, RANTES and TNF-a; P ≤ 0.05), whilst others
were decreased (IL-2, IL-10 and IL-13; P ≤ 0.05) (Figure
1D and Additional file 1, Figure S1).
Embryo recovery and blastocyst cell number
The effect of maternal LPS administration on preim-
plantation embryo development was assessed at GD 3.5.
Maternal LPS had no effect on total number of embryos
recovered or the proportion that were blastocysts (Table
S1 in Additional file 2). However, blastocysts from all
LPS treatments had reduced inner cell mass (ICM) cell
numbers (14% reduced vs. control in the 10 μg/kg LPS
group, P = 0.009; 33% reduced in the 50 and 150 μg/kg
LPS groups, P < 0.001) (Figure 2A). Trophectoderm
(TE) cell numbers were unaffected, except in the 10 μg/
kg LPS group (21% increased, P < 0.001) (Figure 2A).
Total blastocyst cell numbers were increased in the 10
μg/kg LPS group (P = 0.017) and reduced in the 150
μg/kg LPS group (P = 0.004) (Figure 2A). Such altera-
tions in cell numbers resulted in reduced ICM:TE cell
ratios in blastocysts from all LPS treatments (24% to
42% reduced, P ≤ 0.001) (Figure 2B).
Gestation, litter size and offspring growth
Gestation length, male:female ratio, mean birthweight
and litter size were all unaffected, except for increased
litter size in the 10 μg/kg LPS group (P =0 . 0 4 6 )( T a b l e
1). The mean weekly body weights of male and female
offspring from birth to 30 weeks were unaffected (Figure
S2 in Additional file 3).
Offspring behaviour
Integration of all weekly data (nine repeated analyses
over weeks 4 to 23) into mean lifetime open-field
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Page 2 of 12Figure 1 Maternal inflammatory response following treatment with saline or LPS doses. LPS treatment (particularly 50 and 150 μg/kg) (A)
reduced jumping activity and increased time spent resting in an open-field test at one hour posttreatment, (B) reduced food and water
consumption during the first 24 hours posttreatment, (C) reduced body weight at 24 and 48 hours posttreatment (dashed line = preinjection
body weight) and (D) increased serum concentration (pg/mL) of inflammatory cytokines posttreatment. Maternal body weight at each 24-hour
interval posttreatment is expressed as a percentage of pretreatment body weight, as were food and water consumption during each 24-hour
period posttreatment. All values represent means ± standard error of the mean (SEM). *P ≤ 0.05 vs. control (n = 5 to 7 mothers per treatment).
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Page 3 of 12activities showed that 150 μg/kg LPS males displayed
reduced numbers of jumps and rears (reduced by 40%
vs. control, P = 0.015, and reduced by 67% vs. control, P
= 0.027, respectively) (Figure 3A), but no differences in
distance travelled or time spent resting (Figure S3 in
Additional file 4). Mean lifetime open-field activities of
female offspring were unaffected (Figure 3A and Addi-
tional file 4, Figure S3). When open-field activities were
examined on a weekly basis (Figure S4 in Additional file
5), male offspring from 150 μg/kg LPS-treated dams
reared less than controls at weeks 4, 6, 11, 14 and 20
(all P < 0.05), while female offspring from 150 μg/kg
LPS-treated dams reared less than controls only at week
8( P = 0.001). In addition, male offspring from 150 μg/
kg LPS-treated dams jumped less than controls at weeks
6a n d1 7( P < 0.05), and rested longer at week 6 (P =
0.040). No differences between treatments were
observed for females in number of jumps or time spent
resting, and distance travelled was not different between
treatments for males or females (Figure S4 in Additional
file 5). Differences were independent of maternal origin
and gestational litter size.
Offspring systolic blood pressure
Integration of weekly measurements (three repeated
analyses over weeks 16 to 28) into a ‘lifetime’ mean
showed that systolic blood pressure (SBP) was not dif-
ferent, except in male offspring from 10 μg/kg LPS-trea-
ted dams, in which mean lifetime SPB was increased
compared with controls (P = 0.029) (Figure 3B). On a
weekly basis, male offspring from 10 μg/kg LPS-treated
dams displayed increased SBP at weeks 16 and 28 com-
pared with controls (P =0 . 0 3 5a n dP = 0.040, respec-
tively) (Figure S5 in Additional file 6).
Offspring body composition
Analysis of tissue:body weight ratios and body mass
index (BMI) showed that compared with controls, male
offspring from 150 μg/kg LPS-treated dams had a 28%
increase in inguinal fat:body weight ratio (P =0 . 0 3 1 )
(Figure 3C), a 29% increase in retroperitoneal fat:body
weight ratio (P = 0.013) (Figure 3C) and a 7% increase
in BMI (P = 0.033) (Figure 3C), but no differences in
any organ:body weight ratio (Figures S6A and S6D in
Additional file 7). In contrast, females showed no treat-
ment group differences in fat pad:body weight ratio,
BMI (Figure S6B in Additional file 7) or any organ:body
weight ratio (Figure S6C in Additional file 7), except for
liver:body weight ratio, which decreased by 12% in the
50 μg/kg LPS-treated dam group (P =0 . 0 3 3 )( F i g u r e
S6D in Additional file 7). All differences were indepen-
dent of maternal origin and gestational litter size.
Offspring serum cytokine profile
Offspring response to an innate immune challenge was
assessed by measuring serum cytokine concentrations in
LPS-injected (50 μg/kg) adult offspring of dams that
were injected with saline or 10, 50 or 150 μg/kg LPS at
Figure 2 GD 3.5 blastocysts from LPS-treated dams have fewer ICM cells and reduced ICM:TE cell ratios vs. controls. (A) Mean total, TE
and ICM cell numbers and (B) ICM:TE cell ratios. All values represent means ± SEM. *P ≤ 0.05 vs. control (n = 33 to 50 blastocysts per treatment;
n = 4 to 8 mothers per treatment).
Table 1 Gestation and birth data for each maternal treatment group
a
Maternal treatment (μg/
kg LPS)
Number of
mothers
Gestation length
(days)
Total number of
offspring
Mean litter
size
Male:female
ratio
Mean
birthweight (g)
0 (saline control) 6 19 65 10.8 ± 0.6 1.1 ± 0.17 1.62 ± 0.02
10 6 19 82 13.7 ± 0.6* 1.4 ± 0.21 1.57 ± 0.01
50 6 19 76 12.7 ± 0.3 1.0 ± 0.16 1.57 ± 0.01
150 6 19 68 11.3 ± 1.0 1.1 ± 0.18 1.64 ± 0.02
aLPS: lipopolysaccharide. Values represent means ± SEM. *P ≤ 0.05 vs. control.
Williams et al. BMC Biology 2011, 9:49
http://www.biomedcentral.com/1741-7007/9/49
Page 4 of 12Figure 3 MPSI caused dose-dependent, gender-specific abnormalities in adult offspring behaviour and adiposity, but no abnormalities
in systolic blood pressure (SBP). (A) Reduced jumping and rearing open-field activity in male, but not female, offspring from 150 μg/kg LPS
dams. (B) Increased SBP in male offspring from 10 μg/kg LPS dams. (C) Increased fat pad to body weight ratio (%) and BMI in male offspring
from 150 μg/kg LPS dams. All values represent means ± SEM. *P ≤ 0.05 vs. control independent of maternal origin and litter size (n = 6 mothers
per treatment; n = 18 male and 18 female offspring per treatment).
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Page 5 of 12the zygote stage. A selection of the 23 cytokines
detected by the multiplex assay is shown in Figure 4.
The remaining cytokines are shown in Figure S7 in
Additional file 8. At 3.5 hours post-LPS injection, male
and female offspring of LPS-treated dams had severely
blunted serum levels of several cytokines compared
with controls. Notably, the cytokine response of chal-
lenged offspring was either blunted in a maternal LPS
dose-dependent fashion or not altered; in no case did
maternal LPS treatment enhance offspring response.
Challenged males from 10 μg/kg LPS-treated dams (10
LPS) had blunted levels of IL-1a (31% lower, P = 0.03)
and granulocyte colony-stimulating factor (G-CSF)
(99% lower, P = 0.042), while those from 50 μg/kg
LPS-treated dams (50 LPS) had blunted levels of MCP-
1( 9 1 %l o w e r ,P = 0.003), IL-1a, IL-9, IL-10, G-CSF,
MIP-1b (CCL4) and RANTES (26% to 91% lower, all P
< 0.05) and those from 150 μg/kg LPS-treated dams
(150 LPS) had blunted levels of IL-1a,I L - 9( 4 4 %t o
60% lower, all P <0 . 0 1 ) ,I L - 1 b, IL-10, MCP-1, MIP-1b
and RANTES (31% to 75% lower, all P < 0.05). Chal-
lenged females from 10 μg/kg LPS-treated dams had a
serum cytokine profile similar to that of controls. In
contrast, challenged females from 50 μg/kg LPS-treated
dams had blunted levels of IL-1b, IL-12 p40, G-CSF,
keratinocyte-derived chemokine (KC; CXCL1), MCP-1,
MIP-1a,M I P - 1 b,R A N T E Sa n dT N F - a (42% to 99%
lower, all P < 0.01) and those from 150 μg/kg LPS-
treated dams had blunted levels of IL-1b, IL-12 p40,
G-CSF, KC, MCP-1, MIP-1a (40% to 99% lower, all P
<0 . 0 1 ) ,I L - 1 a, IL-2, RANTES and TNF-a (51% to 59%
lower, all P < 0.05).
Offspring serum corticosterone
In addition to serum cytokines, serum corticosterone
concentration was quantified in LPS-injected offspring
from each maternal treatment group (the same groups
described above in ‘Offspring serum cytokine profile’).
Serum corticosterone concentration of LPS-injected off-
spring was unaffected by maternal treatment (Figure S8
in Additional file 9).
Discussion
We have established an in vivo mouse model of MPSI
by intraperitoneal administration of increasing doses of
LPS on the day of zygote formation (GD 0.5) and found
developmental programming to be significantly altered.
We report that MPSI changes blastocyst cellular organi-
sation and induces a complex postnatal phenotype
affecting adult behaviour, adiposity and response to an
innate immune challenge in a gender-specific manner
that is dependent upon the originating maternal LPS
dose. These findings provide new insight into both the
breadth of environmental cues that early embryos are
Figure 4 Serum cytokine concentrations (pg/mL) of adult
offspring from each maternal treatment group 3.5 hours after
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cal systems that are modulated as a consequence.
Maternal response to LPS
Initially, we confirmed induction of an inflammatory
response in LPS-injected dams. LPS treatment caused
metabolic and behavioural changes typically associated
with an inflammatory response, including reduced loco-
motor and exploratory activity, reduced food consump-
tion and body weight, and increased circulating cytokine
and chemokine levels. Long-term changes to offspring
phenotype are known to result from a periconceptional
maternal low-protein diet [2,16,17]. It could therefore be
argued that the indirect effect of reduced food con-
sumption might be the critical inductive event changing
the adult phenotype. We believe this not to be the case,
since (1) maternal food consumption was transiently
reduced by an equivalent amount in all LPS groups,
whilst changes in offspring phenotype were LPS dose-
dependent; (2) reduction in maternal food consumption
was temporally equivalent in all LPS groups, that is,
maternal food consumption in all LPS groups returned
to control levels at an equivalent rate; (3) maternal
serum cytokine levels, a more direct measure of the
inflammatory response, were LPS dose-dependent, cor-
responding with the resultant changes in offspring phe-
notype; and (4) maternal diet-induced programming is
distinct from that reported here and affects particularly
postnatal growth and cardiovascular function [16].
Maternal LPS effect on blastocysts
Administration of LPS, including the low dose, on the
day of zygote formation caused a reduction in GD 3.5
blastocyst ICM cell numbers and ICM:TE cell ratios.
Reduced rodent blastocyst cell numbers have been
induced by maternal protein undernutrition and in vitro
culture and are associated with disease-related changes
in postnatal physiology [2,6]. Similarly, mouse blastocyst
cell numbers have been shown to be altered in response
to maternal nutrition over a wider range [18]. Our cur-
rent findings thus support the concept that altered blas-
tocyst proliferation and lineage allocation may be useful
early markers for diverse forms of developmental pro-
gramming whetherlater effects on foetal and postnatal
growth are induced (maternal protein restriction [16])
or not (current study). We also observed increased TE
cell numbers coinciding with increased litter size only in
the 10 μg/kg LPS group. This may reflect a ‘trophic’
effect mediated by a moderate release of inflammatory
mediators, since cytokines and related signalling mole-
cules are also important factors that are active during
blastocyst development and implantation [19]. A greater
degree of intrauterine growth restriction may have been
exerted by the larger litter size in this low-dose LPS
group and may explain the raised SBP (male offspring)
seen here.
Maternal LPS effects on offspring phenotype
Our most important finding is that MPSI results in
long-term, gender-specific changes to offspring pheno-
type that are associated with a clear maternal LPS dose
dependency. Male offspring from dams treated with the
highest LPS dose displayed reduced locomotor and
exploratory open-field behaviour, increased mass of spe-
cific fat pads, increased BMI and a blunted serum cyto-
kine response to innate (LPS) immune challenge. Male
offspring of the dams injected with the lower LPS doses
(10 and 50 μg/kg) were much less affected, as were
female offspring, which only showed the blunted serum
cytokine response to LPS challenge. Notably, but not
statistically significantly, the locomotor and exploratory
behaviour of female offspring followed the same pattern
as that of the males, suggesting that female behaviour is
affected by MPSI, but to a lesser extent, such that pro-
gramming of offspring behaviour may be graded rather
than dictated by gender. Gender-specific differences in
offspring phenotype have commonly been observed in
DOHaD-related studies [2,6,16,17,20], but the underly-
ing mechanisms are not understood yet. Interestingly,
gender differences are evident in the preimplantation
embryo from conception. For example, male embryos
develop more rapidly than female embryos [21,22] and
consequently may have different sensitivities to distinct
environmental conditions that could thus contribute to
the breadth of the postnatal outcomes discussed in this
section}.
The combined postnatal phenotype, observed espe-
cially in male offspring of mothers that were injected
with the high LPS dose, of reduced locomotor activity,
increased adiposity and blunted cytokine response to
LPS challenge may represent diverse manifestations
from one or more causative pathways. The open-field
behavioural assay has been effective in identifying
broader conditions of ill health in mice, including cardi-
ovascular and metabolic dysfunction [16,17], but pro-
vides symptomatic information rather than mechanistic
insight. The adiposity and BMI outcomes are similar to
those found in an earlier study where 790 μg/kg LPS
administration to rat dams at midgestation caused
LPS challenge. MPSI caused blunted release of predominantly
innate-type cytokines in challenged offspring. A selection is shown
here; the remaining cytokines are shown in Figure S3 in Additional
file 4. All values represent means ± SEM. *P ≤ 0.05 vs. control
independent of maternal origin and litter size (n = 6 mothers per
treatment). Maternal treatments: Sal = saline; 10 LPS = 10 μg/kg
LPS; 50 LPS = 50 μg/kg LPS; 150 LPS = 150 μg/kg LPS.
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altered HPA functionality, but no change in blood pres-
sure or lean body mass, in predominantly male offspring
[12]. A similar offspring phenotype can result from
administration of key inflammatory (IL-6 and TNF-a)
or anti-inflammatory (dexamethasone) mediators during
midgestation [23].
Maternal LPS effect on offspring innate immunity
A novel finding of our study is that MPSI resulted in
adult offspring with a severely blunted serum cytokine
response to innate (LPS) immune challenge. The blunt-
ing was most pronounced in offspring of dams treated
with the highest LPS doses, and, unlike most phenotypic
changes in this study, it affected both male and female
offspring. This blunted response was prominent in cyto-
kines and chemokines (for example, IL-1b and MCP-1)
typically produced by cells of the monocyte lineage (for
example, macrophages), whereas cytokines of the lym-
phocyte lineage (for example, IL-3 and IL-5) were less
affected. Interestingly, Shanks et al. [24] showed that
exposure of neonatal rats to low-dose LPS protected
them from adjuvant-induced arthritis in later life, sug-
gesting a blunted response to infection and inflamma-
tion, in accordance with the findings of the present
study.
Physiologically, the inflammatory response is con-
trolled at a number of levels in a context- and cell-spe-
cific manner [25]; however, major mechanisms include
immunosuppressive signalling via GC pathways, peroxi-
some proliferator-activated receptors (PPARs), regula-
tory T cells (Tregs), alterations in Toll-like receptor
(TLR) sensing and/or signalling pathways and epigenetic
modifications [25-27]. Interestingly, altered expression
of GC receptors (GRs) and PPARs has been found in
offspring born to mothers fed a protein-restricted diet
[28,29], and increased Tregs have been found in cord
blood from neonates born to farm-exposed mothers
[30]. Thus, several pathways with the potential to regu-
late inflammation are known to be susceptible to pro-
gramming influences. In the present study, production
of the major rodent GC, corticosterone, was unaffected
by MPSI, indicating that the blunted offspring cytokine
response was not due to altered GC production.
Furthermore, GCs possess broad immunosuppressive
activity, whilst the blunting observed in this study pre-
dominantly affects innate cytokines. Taken together,
these data support a mechanism that affects innate
immune cells specifically, for example, altered TLR sig-
nalling and/or epigenetic modifications to cytokine pro-
moters. Other aspects of offspring immune status await
investigation.
The blunted cytokine response to LPS challenge is remi-
niscent of the endotoxin tolerance (ET) phenomenon,
wherein transient hyporesponsiveness to endotoxins (LPS)
follows an initial sublethal exposure [31]. However, the
long-lasting intergenerational phenotype of MPSI is dis-
tinct from ET. Crucially, ET is not a state of total unre-
sponsiveness, because LPS signalling in endotoxin-tolerant
cells induces antimicrobial effector functions without con-
comitant expression of inflammatory cytokines [25]. In
this way, the host is protected from a deleterious and
potentially fatal cytokine storm (increased tolerance)
whilst maintaining antipathogen defences (sustained resis-
tance). In animals, host tolerance has been studied far less
extensively than resistance; however, the importance of
tolerance strategies for host survival and host-pathogen
interactions is becoming increasingly known [32-34]. At a
physiological level, we therefore view the current findings
as evidence for a novel form of adaptive response [1]
whereby maternal experience can lead to an increased
level of postnatal tolerance which, within an anticipated
pathogen-rich environment, would protect the offspring
from the cytotoxic effects of their own frequent inflamma-
tory responses. Cytokine hyporesponsiveness in ET is
thought to be regulated at least in part by epigenetic
mechanisms [31], just as metabolic responses are evident
in diet-mediated developmental programming [28,29].
The molecular mechanisms underlying the blunted cyto-
kine response in the current intergenerational model will
be the subject of future research.
Conclusions
In summary, we have identified for the first time that a
maternal periconceptional inflammatory response acts
as a mediator of developmental programming to preim-
plantation embryos. This environmental cue not only
alters the cellular organisation of the blastocyst but also
leads to permanent, gender-specific changes in adult off-
spring behaviour, adiposity and innate immune reactiv-
ity. Adult offspring are hyporesponsive to inflammatory
stimuli which may confer host protection from inflam-
mation-associated tissue damage. These findings in an
animal model extend the repertoire of environmental
conditions that preimplantation embryos are sensitive to
and substantiate the need for broader analysis of under-
lying molecular mechanisms and applicability across
species, including humans.
Methods
Animal treatments
With UK Home Office licence and local ethics commit-
tee approval, MF1 mice were bred in-house at the Uni-
versity of Southampton Biomedical Research Facility
and kept on a 0700 to 1900 hours light cycle with ad
libitum access to standard rodent chow. Virgin females
(7 to 8.5 weeks old and 27 to 33 g in weight) were natu-
rally mated overnight with MF1 studs. The following
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and randomly assigned to receive either sterile saline
(0.85%) or one of the following three LPS (Salmonella
enterica serovar Enteritidis; Sigma, St Louis, MO, USA)
dosages: 10, 50 or 150 μg/kg body weight (freshly pre-
pared on each occasion). Saline or LPS was administered
by intraperitoneal injection of 100-μL volumes between
1400 and 1600 hours on the day of plug (that is, at the
zygote stage, GD 0.5). Mice were returned to their cages
following treatment and were housed individually until
required for experiments.
Maternal inflammatory response
A group of mated females were assessed to character-
ise maternal response to saline (control) or LPS
dosages. A subset from each treatment group were
assessed for sickness-related behaviour and body
weight. At one hour posttreatment, mice underwent an
open-field test (see below in Offspring Analyses: Beha-
viour) to assess locomotor activity. Treated females
and their chow and water bottles were weighed at 0,
24, 48 and 72 hours posttreatment to assess body
weight and consumption of food and water. Another
subset from each treatment group were killed by cervi-
cal dislocation at 3, 24, 48 and 72 hours posttreatment,
maternal blood was collected by cardiac puncture and
serum was aliquoted and stored at -80°C. Maternal
serum cytokine profiles were assessed by using the
Bio-Plex Pro Mouse Cytokine 23-plex panel (Bio-Rad
Laboratories, Hercules, CA, USA).
Embryo recovery and differential nuclear labelling
A group of females from each treatment group were
killed as described above in Maternal inflammatory
response) at GD 3.5, and embryos were flushed from
uteri using prewarmed (37°C) H6 medium with 4 mg/
mL BSA. Freshly collected blastocysts were analysed for
cell numbers within the TE and ICM lineages by differ-
ential nuclear labelling as described previously [35] with
modifications [2]. Blastocysts were viewed and imaged
using a Zeiss Axiovert 200 fluorescence microscope
(Carl Zeiss Ltd, Welwyn Garden City, Hertfordshire,
UK) and MetaMorph version 6.2r6 software (Universal
Imaging Corp.).
Offspring analyses
For assessment of postnatal phenotype, females from
each treatment group were bred to term. At birth, litters
were standardised to six (three median weight offspring
of each gender) and each offspring was assigned a neu-
tral code that did not reflect the treatment group to
which it belonged. Mice were identified by their codes
throughout the study, and the results were not decoded
u n t i ld a t aa n a l y s i sw a sp e r f o r m e da tt h ee n do ft h e
study. Offspring were weaned at three weeks with litter-
mates of the same gender housed together.
Growth
Offspring were weighed weekly from birth to 30 weeks
of age.
Behaviour
Open-field tests were conducted at 4, 5, 6, 8, 11, 14, 17,
20 and 23 weeks. Open-field tests were conducted in
the afternoon in a normally lit room, and, prior to the
test, mice were habituated to the behaviour room for 30
minutes. The open-field arena consisted of a white
acrylic base enclosed on four sides with transparent 0.7-
cm-thick acrylic (dimensions 27.5 × 27.5 × 20 cm,
model ENV-520; Med Associates Inc., Georgia, VT,
USA). Laser beams crossing the open-field arena
allowed animal movement to be detected and recorded
automatically. Each open-field arena was surrounded by
an aluminium shield that prevented the mouse under
investigation from seeing other rodents. Data were
acquired by using Activity Monitor version 4.0 software
(Med Associates Inc.) for a three-minute period which
started as soon as a mouse was detected in the arena
[36]. Each mouse was individually placed in the centre
of the open-field arena, and the distance travelled, time
spent resting, number of jumps and number of rears
was recorded by the computer. After each three-minute
recording period, the mouse was returned to its home
cage and the open-field arena was cleared of any drop-
pings and wiped out with disinfectant solution and
paper towels.
Systolic blood pressure
SBP was measured at 16, 22 and 28 weeks of age by tail
cuff plethysmography [6] using an ITC model 229 blood
pressure monitor (Linton Instruments, Norfolk, UK).
SBP was taken at room temperatures of 27°C to 30°C, to
which we allowed the mice to acclimatise themselves for
60 minutes prior to measurement. This practice
encourages vasodilatation, thus facilitating detection of
SBP. Mice were restrained in a ventilated acrylic tube,
and their tails were threaded through the tail cuff. Each
mouse was allowed to become acclimatised to the appa-
ratus for five minutes prior to readings’ being taken. At
each time point, five sequential SBP readings were taken
for each mouse, and the mean value of the three median
readings was calculated and recorded.
Terminal treatments, blood collection and body
composition
Offspring were killed by cervical dislocation at 40 weeks
of age. Three and one-half hours before they were killed,
a subset of male and female littermates were injected
with 50 μg/kg LPS (as described above in Animal treat-
ments). Blood was collected by cardiac puncture, then
major organs (heart, lungs, liver, brain and left and right
kidneys) and fat pads (interscapular, retroperitoneal,
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weighed. Serum was extracted from blood samples and
stored at -80°C.
Serum cytokine profiles
Offspring (and maternal, see above in Maternal
inflammatory response{) serum cytokine profiles were
assessed using the Bio-Plex Pro Mouse Cytokine 23-
plex panel (Bio-Rad Laboratories) as per the manufac-
turer’s instructions. Before analysis, thawed serum
samples were diluted 1:4 using Bio-Plex mouse serum
diluent (Bio-Rad Laboratories) as recommended by
the manufacturer. Prepared plates were run on a
Luminex 100 instrument (Luminex Corp., Austin, TX,
USA) equipped with STarStation version 2.0 software
(Applied Cytometry, Sheffield, Yorkshire, UK).
Unknown sample cytokine concentrations were auto-
matically calculated by the STarStation software based
on a nine-point standard curve (in duplicate) fitted
with a four- or five-parameter logistic regression algo-
rithm to allow a wide range of quantification, and R
2
values were routinely > 0.95. Of the 23 cytokines ana-
lysed by using this kit, most had a lower limit of
detection that was < 3 pg/mL and an upper limit of
detection that was well in excess of 15,000 pg/mL.
Intra-assay coefficients of variation were routinely <
15%, indicating a good level of precision. Please refer
to Bio-Rad Bulletin 3156 for a detailed summary of
the performance characteristics of the Bio-Plex Pro
Mouse Cytokine 23-plex panel that we used. The pro-
file of the cytokines analysed was IL-1a,I L - 1 b,I L - 2 ,
IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 p40, IL-12
p70, IL-13, IL-17, eotaxin (CCL11), G-CSF, GM-CSF,
IFN-g, KC, MCP-1, MIP-1a,M I P - 1 b,R A N T E Sa n d
TNF-a.
Serum corticosterone concentrations
Offspring serum corticosterone levels were measured
using a quantitative competitive ELISA kit (AssayMax
Corticosterone ELISA Kit; AssayPro, St. Charles, MO,
USA).
Statistical analysis
All statistics were calculated using SPSS version 14 soft-
ware (SPSS Inc., Chicago, IL, USA). One-way analysis of
variance with the Bonferroni correction was used to
analyse all maternal, birth and blastocyst cell number
data. All postnatal data were analysed using a multilevel
random effects regression model without the Bonferroni
correction, which enabled accurate consideration of the
hierarchical nature of the data set with between-mother
and within-mother variation and incorporation of gesta-
tional litter size [16,37]. Thus, differences identified
between treatment groups are independent of maternal
origin of litter and litter size.
Additional material
Additional file 1: Figure S1. Maternal serum cytokine concentrations
(pg/mL) 3 to 72 hours following treatment with saline or LPS. Bars:
maternal LPS treatment; white: saline control; dark: 10 μg/kg; light: 50
μg/kg; hatched: 150 μg/kg. All values represent means ± SEM. *P ≤ 0.05
compared with control (n = 5 to 7 mothers per treatment). The
multiplex assay allowed us to detect and quantify the full concentration
range of every cytokine at every time point examined, except for G-CSF,
KC and IL-6 at three hours postinjection. The data presented here for G-
CSF, KC and IL-6 at three hours postinjection are underrepresentative of
actual concentrations, particularly for the LPS-treated groups (indicated
by ! on graphs).
Additional file 2: Table S1. Embryos flushed from control and LPS-
treated mothers at GD 3.5. Values represent means ± SEM (n = 4 to 8
mothers per treatment).
Additional file 3: Figure S2. No difference in growth of female or
male offspring from birth to 30 weeks. Values represent means ± SEM
independent of maternal origin and litter size (n = 6 mothers per
treatment; n = 18 male and 18 female offspring per treatment).
Additional file 4: Figure S3. Lifetime mean distance travelled and
time spent resting by adult offspring in the open-field behavioural
test. Bars: maternal LPS treatment; white: saline control; dark: 10 μg/kg;
light: 50 μg/kg; hatched: 150 μg/kg. Values represent means ± SEM
independent of maternal origin and litter size (n = 6 mothers per
treatment; n = 18 male and 18 female offspring per treatment).
Additional file 5: Figure S4. Individual weekly open-field activity of
adult male and female offspring. Values represent means ± SEM. *P ≤
0.05 vs. control independent of maternal origin and litter size (n =6
mothers per treatment; n = 18 male and 18 female offspring per
treatment).
Additional file 6: Figure S5. Individual weekly systolic blood
pressure (SBP) of adult male and female offspring. Values represent
means ± SEM. *P ≤ 0.05 vs. control independent of maternal origin and
litter size (n = 6 mothers per treatment; n = 18 male and 18 female
offspring per treatment).
Additional file 7: Figure S6. Body composition of adult offspring. (A)
Organs to body weight (%) of males. (B) Fat pad to body weight ratio
(%) and BMI of females. (C) Organs to body weight ratio (%) of females.
(D) Liver to body weight ratio (%) in males and females. All values
represent means ± SEM. *P ≤ 0.05 vs. control independent of maternal
origin and litter size (n = 6 mothers per treatment; n = 18 male and 18
female offspring per treatment).
Additional file 8: Figure S7. Serum cytokine concentrations (pg/mL)
of adult offspring from each maternal treatment group 3.5 hours
after LPS challenge. Values represent means ± SEM. *P ≤ 0.05 vs.
control independent of maternal origin and litter size (n = 6 mothers per
treatment). Maternal treatments: Sal = saline; 10 LPS = 10 μg/kg LPS; 50
LPS = 50 μg/kg LPS; 150 LPS = 150 μg/kg LPS.
Additional file 9: Figure S8. Serum corticosterone concentration
(ng/mL) of adult offspring from each maternal treatment. Values
represent means ± SEM (n = 6 mothers per treatment). Maternal
treatments: Sal = saline; 10 LPS = 10 μg/kg LPS; 50 LPS = 50 μg/kg LPS;
150 LPS = 150 μg/kg LPS.
Abbreviations
BMI: body mass index; BSA: bovine serum albumin; DOHaD: developmental
origins of health and disease; ELISA: enzyme-linked immunosorbent assay;
ET: endotoxin tolerance; GD: gestational day; GR: glucocorticoid receptor;
HPA: hypothalamic-pituitary-adrenal; ICM: inner cell mass; IFN: interferon; IL:
interleukin; LPS: lipopolysaccharide; MPSI: maternal periconceptional systemic
inflammation; PPAR: peroxisome proliferator-activated receptor; SBP: systolic
blood pressure; TE: trophectoderm; TLR: Toll-like receptor; TNF: tumour
necrosis factor.
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